.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Ulrich Schüller

Hamburg, DE

University Hospital Hamburg-Eppendorf

Vorsitz

15.09.2023
09:00 – 10:30
Scientific session - Cross-field
Reshaping disease concepts 2: Proteomics in neuropathology
Lecture Hall (2nd floor)
large auditorium, 500 seats

Industrial Speaker

15.09.2023
13:05 – 13:25 20 Min. 0 Min.
Industrial Talk
Implementation of Nanopore sequencing in routine CSF diagnostics

Weitere Beteiligungen

14.09.2023
ePoster
eP-NO-A132
Molecular and clinical characterization of atypical neurofibromas
14.09.2023
ePoster
PS7-NO-A66
Morphology-based molecular classification of spinal cord ependymomas using deep neural networks
14.09.2023
ePoster
S14-NO-A36
Mean global DNA methylation serves as independent prognostic marker in glioblastoma, IDH wildtype
14.09.2023
ePoster
PS1-NO-A55
Characterisation of gene fusions in MYB(L1)-altered gliomas
14.09.2023
ePoster
PS6-NO-A62
Proteome signatures are closely associated with histomorphology in Embryonal Tumors with Multilayered Rosettes (ETMR)
14.09.2023
13:21 – 13:27 4 Min. 2 Min.
ePoster Talk
PS1-NO-A55
Characterisation of gene fusions in MYB(L1)-altered gliomas
14.09.2023
17:30 – 17:36 4 Min. 2 Min.
Flash Talk
S14-NO-A36
Mean global DNA methylation serves as independent prognostic marker in glioblastoma, IDH wildtype
15.09.2023
09:50 – 10:00 7 Min. 3 Min.
Abstract Talk
S15-NO-A32
Integrated multiomic analyses of medulloblastoma using bulk proteome and DNA-methylome data reveals subtype-specific targetable alterations
15.09.2023
12:57 – 13:03 4 Min. 2 Min.
ePoster Talk
PS7-NO-A66
Morphology-based molecular classification of spinal cord ependymomas using deep neural networks
15.09.2023
13:15 – 13:21 4 Min. 2 Min.
ePoster Talk
PS6-NO-A62
Proteome signatures are closely associated with histomorphology in Embryonal Tumors with Multilayered Rosettes (ETMR)
15.09.2023
18:20 – 18:30 7 Min. 3 Min.
Abstract Talk
S24-NO-A20
Epigenetically defined angiocentric gliomas may lack angiocentric growth and instead show a variety of growth patterns
15.09.2023
18:40 – 18:50 7 Min. 3 Min.
Abstract Talk
S24-NO-A19
Transcriptomic and epigenetic dissection of spinal ependymomas (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation
16.09.2023
09:50 – 10:00 7 Min. 3 Min.
Abstract Talk
S26-NO-A31
Classification of brain tumors by Nanopore sequencing of cell-free DNA from cerebrospinal fluid